[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$ttiv Graphic](https://lunarcrush.com/gi/w:26/t:$ttiv.png) $ttiv

$TTIV sees mixed signals as investors react to biotech news. A major buyout in the obesity and liver disease space is driving investor interest in related small-cap innovators like $TTIV, but engagements are down overall.

### About $ttiv
A cryptocurrency.  

### Engagements: XX [#](/topic/$ttiv/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ttiv/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ttiv/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Month**: XXX +124%  
**1-Year High**: XXXXX on 2025-05-05  
**1-Year Low**: X on 2025-10-14  

| Social Network | X  |
| -------------- | -  |
| Engagements    | XX |
  

  
  
### Mentions: X [#](/topic/$ttiv/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ttiv/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ttiv/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1-Year High**: X on 2025-09-30  
**1-Year Low**: X on 2025-05-05  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$ttiv/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ttiv/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ttiv/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $ttiv in the last XX hours which is up XXX% from X in the previous XX hours
**Daily Average**: X  
**1-Year High**: X on 2025-07-30  
**1-Year Low**: X on 2025-05-05  

**Top assets mentioned**
In the posts about $ttiv in the last XX hours

[Akropolis (AKRO)](/topic/$akro)

**Top topics mentioned**
In the posts about $ttiv in the last XX hours

[acquisition](/topic/acquisition), [novo](/topic/novo), [$52b](/topic/$52b), [$akro](/topic/$akro), [$tti](/topic/$tti), [$ttipf](/topic/$ttipf), [$novcde](/topic/$novcde)

### Top Social Posts [#](/topic/$ttiv/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Large-cap pharmas renewed buying spree in metabolic and genetic disease continues with Novo Nordisks $5.2B acquisition of $AKRO underscoring surging interest in MASH and mitochondrial-linked disorders. $TTI.v $TTIPF Notably $AKRO's EFX targets mechanisms tied to oxidative stress similar to @thiogenesis's cysteamine-based platform addressing oxidative and mitochondrial dysfunction across rare and metabolic diseases. With three Phase X programs in MELAS Leigh Syndrome and pediatric MASH $TTI offers diversified exposure to these fast-moving therapeutic areas. Backed by extended IP through 2038"  
[X Link](https://x.com/StckMasterFlash/status/1978583822028730847) [@StckMasterFlash](/creator/x/StckMasterFlash) 2025-10-15T22:08Z 3027 followers, XXX engagements


"#BioTech @thiogenesis $TTI $TTI.v $TTIPF Another major buyout in the obesity & liver disease space Novo Nordisk acquiring $AKRO for up to $5.2B Notably $AKRO's drug treats compensated cirrhosis due to MASH the same disease $TTI is addressing through its Phase X pediatric MASH program part of a broader pipeline tackling oxidative stress & mitochondrial dysfunction Meanwhile $SHRX $SHRX.v also surged +107% today highlighting investor interest in small-cap innovators targeting rare inherited diseases like $TTI When biotech hits it HITS💥"  
[X Link](https://x.com/TheTSXDude/status/1976770448928260099) [@TheTSXDude](/creator/x/TheTSXDude) 2025-10-10T22:02Z 2613 followers, XXX engagements